Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 8 publications
Safety and Efficacy of Dexpramipexole in Eosinophilic Asthma (EXHALE): A randomized controlled trial.
Journal: The Journal of allergy and clinical immunology
Published: February 03, 2023
Dexpramipexole depletes blood and tissue eosinophils in nasal polyps with no change in polyp size.
Journal: The Laryngoscope
Published: August 10, 2018
Dexpramipexole as an oral steroid-sparing agent in hypereosinophilic syndromes.
Journal: Blood
Published: February 22, 2018
Association Between Decline in Slow Vital Capacity and Respiratory Insufficiency, Use of Assisted Ventilation, Tracheostomy, or Death in Patients With Amyotrophic Lateral Sclerosis.
Journal: JAMA neurology
Published: November 29, 2017
The targeted eosinophil-lowering effects of dexpramipexole in clinical studies.
Journal: Blood cells, molecules & diseases
Published: December 22, 2016
A post hoc analysis of subgroup outcomes and creatinine in the phase III clinical trial (EMPOWER) of dexpramipexole in ALS.
Journal: Amyotrophic lateral sclerosis & frontotemporal degeneration
Published: August 16, 2014
Dexpramipexole versus placebo for patients with amyotrophic lateral sclerosis (EMPOWER): a randomised, double-blind, phase 3 trial.
Journal: The Lancet. Neurology
Published: September 27, 2013
The effects of dexpramipexole (KNS-760704) in individuals with amyotrophic lateral sclerosis.
Journal: Nature medicine
Published: October 20, 2011
Showing 1-8 of 8
Last Updated: 09/26/2026